Sharemaestro Newsreel

GE HealthCare Technologies Inc. stock rises Friday, outperforms market

Shares of GE HealthCare Technologies Inc. (GEHC) rose 2.08% to $71.77 on Friday, outperforming the broader market. The S&P 500 Index (SPX) increased by 0.62%, and the Dow Jones Industrial Average (DJIA) climbed 0.28%. This marks the second consecutive day of gains for the …

Mobia Medical Inc expected to post a loss of 63 cents a share - Earnings Preview

Mobia Medical Inc (MOBI) is anticipated to report a loss of 63 cents per share. This information is provided as an earnings preview from Refinitiv, with the full article accessible via a TradingView subscription.

CONMED Corporation (CNMD) Stock Forecasts

Argus has raised its target price for CONMED Corporation (CNMD) to $53.00. The medical equipment company, based in Utica, New York, specializes in sports medicine procedures and general surgeries. The current stock price for CNMD is $49.12.

iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition

iRhythm has announced the acquisition of VitalConnect for $287.5 million, a move aimed at expanding its cardiac monitoring platform across various healthcare settings. The deal, expected to close by the end of 2026, combines cash and iRhythm common stock. This acquisition is anticipated to …

Enovis Corp (ENOV) Stock News Today

TELA Bio Inc expected to post a loss of 18 cents a share - Earnings Preview

TELA Bio Inc is projected to report an earnings loss of 18 cents per share, according to a Refinitiv earnings preview. The article, sourced from Reuters via TradingView News, indicates that this forecast is for an upcoming earnings report.

Treace Medical Concepts earnings beat by $0.06, revenue topped estimates

Treace Medical Concepts (NASDAQ: TMCI) reported a second-quarter EPS of $-0.24, surpassing the analyst estimate of $-0.30 by $0.06. The company's revenue for the quarter reached $45.4 million, exceeding the consensus estimate of $43.94 million. Despite a 117.91% increase in its stock price over …

TriSalus Life Sciences (NASDAQ:TLSI) Posts Quarterly Earnings Results, Meets Expectations

TriSalus Life Sciences (NASDAQ:TLSI) announced its quarterly earnings, reporting a loss of $0.16 per share, which met analyst expectations, while revenue exceeded estimates at $11.41 million. The company's gross margin improved to 86.8%, and management reiterated its 2026 revenue guidance of $54 million to …

Glaukos (NYSE: GKOS) insider Alex R. Thurman plans 20,000-share stock sale

Glaukos Corporation insider Alex R. Thurman has filed a Form 144 to sell 20,000 common shares, valued at approximately $3.6 million, stemming from a stock option exercise on August 7, 2026. This proposed sale follows three previous sales by Thurman in the past three …

Needham Maintains Steris PLC(STE.US) With Hold Rating

Needham has reiterated its Hold rating on Steris PLC (STE.US). This indicates that the analyst firm is advising investors to maintain their current position in the stock without buying or selling.

Steris PLC stock outperforms competitors on strong trading day

Shares of Steris PLC (STE) rose 2.45% on Friday to $237.47, outperforming the broader market which also saw gains with the S&P 500 Index up 0.62% and the Dow Jones Industrial Average rising 0.28%. This strong performance ended a two-day losing streak for the …

Owlet Inc (OWLT) Stock News Today

Lifeward Out With Q2 Numbers

Lifeward Ltd. (NASDAQ: LFWD), a biomedical innovation company, announced it will report its second-quarter 2026 financial results on Friday, August 14. The company has a portfolio of neurorehabilitation products and is expanding into diversified biomedical platforms, including its Protein Oral Delivery (POD™) platform for …

Cytosorbents Corp (CTSO) Stock News Today

This article provides recent news and financial updates for Cytosorbents Corp (CTSO). The company's stock experienced a 9.68% decline. The latest earnings report indicates that CytoSorbents' Q2 2026 earnings showed improved margins despite flat revenue.

Nano-X Imaging (NASDAQ: NNOX) completes $8.0M registered direct offering

Nano-X Imaging Ltd. (NNOX) has completed an $8.0 million registered direct offering with a single institutional investor. The offering included 8,000,000 ordinary shares (or pre-funded warrants) and 8,000,000 ordinary warrants, with proceeds intended for working capital and general corporate purposes. A.G.P./Alliance Global Partners served …

Top Stock Reports for SpaceX, Arista Networks & Boeing

Friday, August 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Space Exploration Technologies Corp. (SPCX), Arista Networks, Inc. (ANET) and The Boeing Co. (BA). These …

iRhythm Technologies Inc (IRTC) Stock News Today

This article provides current stock information for iRhythm Technologies Inc (IRTC), including its stock price, market capitalization, and a note that more news is coming soon. It also lists various financial and analytical tools available on the TradingKey platform for investors.

908 Devices Inc. (MASS) director sells 20,000 shares under trading plan

Christopher D. Brown, a director at 908 Devices Inc. (MASS), sold 20,000 shares of common stock on August 5, 2026, at a weighted average price of $8.49 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on November 24, 2025. …

Non-operating income (total) of Insulet Corporation – HAM:GOV

This article provides financial data for Insulet Corporation (HAM:GOV) specifically focusing on its non-operating income (total). The data is presented within the context of the Hamburg Stock Exchange, though no specific values are listed in the provided content. It serves as a placeholder for …

Trinity Biotech PLC (TRIB) Stock News Today

This article provides current stock information for Trinity Biotech PLC (TRIB), showing its recent trading performance with a 6.79% increase. It notes that more news is expected soon regarding earnings, analyst ratings, and key developments. The page also includes financial data like market capitalization.

Malvern company TELA Bio announces new CEO

TELA Bio, a Malvern-based medical technology company, has appointed Heather Getz as its new CEO and director, effective August 4. Getz replaces co-founder Antony Koblish and brings extensive experience in driving operational excellence and financial transformations from her previous roles at Butterfly Network and …

Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...

Treace Medical Concepts Inc (TMCI) reported a 4% revenue decline to $45.4 million in Q2 2026, though adjusted EBITDA loss narrowed and cash usage significantly decreased. The company is experiencing increased adoption of new bunion systems and expects improved performance in the latter half …

Treace Medical Concepts Releases Q2 2026 Financial Results

Treace Medical Concepts, Inc. (TMCI) reported a narrower Q2 2026 loss per share of -$0.24, beating the -$0.30 estimate by 20.0%. The company's revenue for the quarter was $45.4 million, representing a 4.0% year-over-year decrease. Management projects full-year revenue to be between $204.0 million …

TriSalus Life Sciences earnings missed by $0.01, revenue topped estimates

TriSalus Life Sciences (NASDAQ: TLSI) reported second-quarter EPS that missed analyst estimates by $0.01, coming in at $-0.160. However, the company's revenue for the quarter exceeded expectations, reaching $11.41 million against a consensus estimate of $10.79 million. Despite the EPS miss, TriSalus Life Sciences' …

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

Tandem Diabetes Care, Inc. reported strong financial results for Q2 2026, with worldwide sales increasing 6% to $254.6 million and gross margin up 460 basis points to 57%. The company also highlighted strategic achievements, including FDA submissions for Tandem Mobi, expanded global technology solutions, …

Tandem Diabetes Care Inc (TNDM) News, Articles, Events & Latest Updates

Tandem Diabetes Care Inc (TNDM) reported Q2 2026 financial results, including a loss and lagging revenue estimates, despite some key metrics showing positive movement. The company announced upcoming conference presentations, product compatibility expansions, and plans to release Q2 results in August 2026. This news …

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.31, which beat estimates by $0.01. The company's revenue for the quarter was $254.56M, representing a 5.77% year-over-year increase, though it missed revenue expectations by $510.18K. The slide deck …

Neuronetics Inc expected to post a loss of 12 cents a share - Earnings Preview

Neuronetics Inc is projected to report a loss of 12 cents per share, according to an earnings preview. The article, sourced from Reuters, provides this financial expectation. Readers can access the full article through TradingView.

QUANTERIX Q2 2026 Earnings Preview: Recent $QTRX Insider Trading, Hedge Fund Activity, and More

Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary

Elutia Receives Nasdaq Notice on Listing Compliance Risk

Elutia Inc. (ELUT) received a notice from Nasdaq stating that its Class A common stock has fallen below the minimum $1.00 per share bid price for 30 consecutive business days, putting it at risk of delisting. The company has until February 2, 2027, to …

Elutia Inc. (NASDAQ: ELUT) faces Nasdaq minimum bid price deficiency

Elutia Inc. (NASDAQ: ELUT) has received a notice from Nasdaq stating that its Class A common stock has traded below the $1.00 minimum bid price for 30 consecutive business days, failing to meet the continued listing requirement. The company has 180 calendar days, until …

Smith & Nephew Is Under Pressure from External Factors and Portfolio Gaps

Smith & Nephew (SNN) is facing pressure due to external factors and gaps in its product portfolio, despite its history of innovation in orthopedics, sports medicine, and wound care markets. The company has shown strength in introducing innovations like Oxinium technology for hip replacements …

IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for IRIDEX Corp (IRIX), indicating a current earnings forecast score of 8.00 and a "Buy" rating based on one analyst. It details future revenue and EPS expectations, with an anticipated next-quarter revenue of $12.98 million and an EPS …

Net current asset value per share of Insulet Corporation – HAM:GOV

This article displays the "Net current asset value per share" for Insulet Corporation (GOV) on the Hamburg Stock Exchange. The current financial data for the specified period is not available, showing "No trades" as the market is closed. The content primarily consists of navigation …

Boston Scientific (NYSE: BSX) director adds 2,100 shares in open-market buy

Boston Scientific director David C. Habiger purchased 2,100 shares of common stock on August 5, 2026, in an open-market transaction. The shares were bought at a weighted average price of $47.589, with individual trade prices ranging from $47.21 to $47.98. Following this transaction, Habiger …